X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/15/2862624/0/en/Athira-Pharma-Appoints-Javier-San-Martin-M-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2024/04/11/2861365/0/en/Athira-Pharma-Announces-Publication-of-Preclinical-Data-Highlighting-Fosgonimeton-Treatment-in-Models-of-Alzheimer-s-Disease.html
https://www.globenewswire.com/news-release/2024/04/03/2856770/0/en/Athira-Pharma-Announces-Upcoming-Poster-Presentation-at-American-Academy-of-Neurology-AAN-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/08/2843025/0/en/Athira-Pharma-Presents-Clinical-and-Preclinical-Data-Supporting-Therapeutic-Potential-of-Fosgonimeton-in-Alzheimer-s-and-Parkinson-s-Diseases-at-AD-PD-2024-International-Conference.html
https://www.globenewswire.com//news-release/2024/02/22/2834070/0/en/Athira-Pharma-Reports-Full-Year-2023-Financial-Results-and-Pipeline-and-Business-Updates.html
https://www.globenewswire.com//news-release/2024/02/08/2826428/0/en/Athira-Pharma-Announces-Publication-in-Frontiers-in-Neuroscience-Highlighting-Therapeutic-Potential-of-ATH-1105-in-Amyotrophic-Lateral-Sclerosis-ALS.html
https://www.globenewswire.com//news-release/2024/01/08/2805247/0/en/Athira-Pharma-Provides-2024-Clinical-Pipeline-Outlook-and-Business-Update.html
https://www.globenewswire.com//news-release/2024/01/03/2803137/0/en/Athira-Pharma-Completes-Enrollment-of-Phase-2-3-LIFT-AD-Clinical-Trial-of-Fosgonimeton-in-Mild-to-Moderate-Alzheimer-s-Disease.html
https://www.globenewswire.com//news-release/2023/12/12/2794592/0/en/Athira-Pharma-Announces-Encouraging-Results-from-SHAPE-Phase-2-Clinical-Trial-of-Fosgonimeton-for-the-Treatment-of-Parkinson-s-Disease-Dementia-and-Dementia-with-Lewy-Bodies.html
https://www.fiercebiotech.com/biotech/athiras-losing-streak-continues-phase-2-failure-dementia
Market Place
Share 
